Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T08:12:44.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Pupil Studies in Depressed Patients: An Investigation of the Mechanism of Action of Desipramine

Published online by Cambridge University Press:  29 January 2018

Eric Shur  and
Stuart Checkley
Eric Shur
Affiliation:
Institute of Psychiatry, London SE5 and Honorary Senior Registrar, Maudsley Hospital, Denmark Hill, London SE5 8AZ
Stuart Checkley
Affiliation:
Maudsley Hospital
Get access Rights & Permissions [Opens in a new window]

Summary

Six depressed patients were treated routinely with desipramine, a relatively selective noradrenergic uptake blocking drug. After 0, 1 and 3 weeks' treatment pupillary responses to tyramine, phenylephrine and pilocarpine were measured using a photographic technique. Both 1 and 3 weeks' treatment significantly inhibited tyramine and phenylephrine-induced mydriasis, but did not inhibit pilocarpine-induced miosis; in fact the longer treatment enhanced miosis due to pilocarpine. Resting pupil size was significantly increased after 1 and 3 weeks' treatment.

The findings can be explained by the known ability of desipramine to block noradrenaline uptake and α adrenoceptors: they provide no evidence of muscarinic receptor blockade or of a slowly developing adaptation at a adrenoceptors.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 140 , Issue 2 , February 1982 , pp. 181 - 184
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bergstrom, D. A. & Kellar, K. F. (1979) Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. Journal of Pharmacology and Experimental Therapeutics, 209, 256–61.Google Scholar
Checkley, S. A., Slade, A. P., Shur, E. & Dawung, S. (1981) A pilot study of the mechanism of action of desipramine. British Journal of Psychiatry, 138, 248–51.Google Scholar
Crews, F. T. & Smith, C. B. (1978) Pre-synaptic alpha-receptor subsensitivity after long-term anti-depressant treatment. Science, 202, 322–4.Google Scholar
Gazner, P., Szabadi, E. & Bradshaw, C. M. (1980) Comparison of the effects of desipramine and amitriptyline on pupillary responses to noradrenaline and methoxamine in healthy volunteers. British Journal of Clinical Pharmacology, 9, 307–9.Google Scholar
Ghose, K. (1976) Correlation of pupil reactivity to tyramine or hydroxyamphetamine and tyramine pressor responses in patients treated with amitriptyline or mianserin. British Journal of Clinical Pharmacology, 3, 666–7.Google Scholar
Ghose, K., Coppen, A. & Turner, P. (1976) Autonomic actions and interactions of mianserin hydrochloride (Org.GB.94) and amitriptyline in patients with depressive illness. Psychopharmacology, 49, 201–4.Google Scholar
Green, J. P. & Maayani, S. (1977) Tricyclic antidepressants block histamine H2 receptors in the brain. Nature, 269, 163–5.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–96.Google Scholar
Iversen, L. L. (1965) The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge University Press.Google Scholar
Kanof, P. D. & Greengard, P. (1978) Brain histamine receptors as targets for antidepressant drugs. Nature, 272, 329–33.Google Scholar
Maggi, A., U'Pritchard, D. C. & Enna, S. J. (1980) Differential effects of antidepressant treatment of brain monoaminergic receptors. European Journal of Pharmacology, 61, 91–8.Google Scholar
Peroutka, S. J. & Snyder, S. H. (1980) Long-term antidepressant treatment decreases spiroperidollabelled serotonin receptors. Science, 210, 88—90.CrossRefGoogle Scholar
Randrup, A. & Braestrup, C. (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacology, 53, 309–14.CrossRefGoogle Scholar
Sellinger-Barnette, M. M., Mendels, J. & Frazer, A. (1980) The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain. Neuropharmacology, 19, 447–54.Google Scholar
Sneddon, J. M. (1968) Interactions of Sympathomimetic Drugs in the Eye. Ph.D. Thesis. University of London.Google Scholar
Sneddon, J. M. & Turner, P. (1969) The interactions of local guanethidine and sympathomimetic amines in the human eye. Archives of Ophthalmology, 81, 622–7.Google Scholar
Snyder, S. H. & Yamamura, H. I. (1977) Antidepressants and the muscarinic acetylcholine receptor. Archives of General Psychiatry, 34, 236–9.Google Scholar
Spitzer, R. L., Endicott, J. & Robins, E. (1977) Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders. 3rd Edition. New York: New York State Psychiatric Institute.Google Scholar
Svensson, T. H. & Usdin, T. (1978) Feedback inhibition of brain noradrenaline neurones by tricyclic antidepressants: a receptor mediation. Science, 202, 1089–91.Google Scholar
Szabadi, E., Besson, J. & Bradshaw, C. M. (1975) Pupil responsiveness to tyramine in depressed patients treated with amitriptyline. British Journal of Clinical Pharmacology, 2, 362–3.Google Scholar
Szabadi, E., Gaszner, P. & Bradshaw, C. M. (1980) The peripheral anticholinergic activity of tricyclic antidepressants: Comparison of amitriptyline and desipramine in human volunteers. British Journal of Psychiatry, 137, 433–9.Google Scholar
Trendelenburg, U. (1972) Classification of sympathomimetic amines. In Handbook of Experimental Pharmacology, Vol. 33, Catecholamines (eds. Blaschko, H. and Muscholl, E.), pp 337–38. Berlin and Heidelberg: Springer-Verlag.Google Scholar
Turner, P. (1975) The human pupil as a model for clinical pharmacological investigation. Journal of the Royal College of Physicians of London, 9, 165–71.Google Scholar
U'Pritchard, D. C., Greenberg, D. A., Sheehan, P. P. & Snyder, S. H. (1978) Tricyclic antidepressants: therapeutic properties and affinity for α-noradrenergic binding sites in the brain. Science, 199, 197–8.Google Scholar
Vetulani, J., Stawarz, R. J., Dingell, J. U. & Sulser, F. (1976) A possible common mechanism of action of antidepressant treatments. Naunyn-Schmiedeberg's Archives of Pharmacology, 293, 109–14.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.